GEN Exclusives

More »

GEN News Highlights

Back to Item »

EC Approves BMS and AstraZeneca’s Type 2 Diabetes Therapy for Renally Impaired Patients

Onglyza 2.5 mg can now be used to treat individuals with moderate-to-severe renal impairment.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Stopping Research Fraud

What is the best approach to curbing scientific misconduct and outright fraud?